SELENBP1 and adenocarcinoma: Downregulation of SELENBP1 in Barrett’s esophagus to adenocarcinoma progression could enhance apoptosis, cellular senescence, and cisplatin cytotoxicity in EAC cells (Silvers et al., 2010).